Acelyrin, Inc. (NASDAQ: SLRN)
$2.0300
-0.0700 ( -5.58% ) 549.0K
Acelyrin Inc is a late-stage clinical biopharmaceutical company. It is focused on providing patients life-changing new treatment options by identifying, acquiring, and accelerating development and commercialization of of transformative medicines.
Market Data
Open
$2.0300
Previous close
$2.1000
Volume
549.0K
Market cap
$203.66M
Day range
$2.0210 - $2.1610
52 week range
$1.9100 - $8.8850
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 10-q | Quarterly Reports | 77 | Aug 13, 2024 |
| 4 | Insider transactions | 1 | Jul 19, 2024 |
| 4 | Insider transactions | 1 | Jun 11, 2024 |
| 4 | Insider transactions | 1 | Jun 11, 2024 |
| 4 | Insider transactions | 1 | Jun 11, 2024 |
| 4 | Insider transactions | 1 | Jun 11, 2024 |
| 4 | Insider transactions | 1 | Jun 11, 2024 |
| 4 | Insider transactions | 1 | Jun 11, 2024 |
| 4 | Insider transactions | 1 | Jun 11, 2024 |
| 8-k | 8K-related | 13 | Jun 11, 2024 |